Related Tags >> China FDA emerging markets Generics

India News

Most Popular India Story

Mylan inks deal for generic biologics

June 29, 2009 — 9:05am ET | By Tracy Staton

Biocon, India's biggest biotechnology company, signed an agreement with Mylan to develop, make and market generic biologic drugs. Report... Read more...

India Press Releases

GVK Biosciences Forms Clinical Research Alliance with Excel PharmaStudies, to Conduct Trials in India and China
Bristol-Myers Squibb and Biocon's Syngene Open New R&D Facility at Biocon Park
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
FDA Takes New Regulatory Action Against Ranbaxy's Paonta Sahib Plant in India
India's Breast Cancer Drug Market Will Almost Double by 2012

Latest Headlines

Mylan inks deal for generic biologics
June 29, 2009
China, India loom large on FDA to-do list
May 18, 2009
Indian pharma exports drop 40% in downturn
May 11, 2009
Will Obama tax reforms quash outsourcing?
May 7, 2009
Indian ministers: Protect pharma from takeover
May 4, 2009
Paper: Sanofi bid for Piramal falters
April 6, 2009
Global drugmakers invade Indian market
April 3, 2009
Novartis to increase stake in Indian subsidary
March 25, 2009
Big Pharma eyes rural India for growth
March 19, 2009
Indian drugmakers push into U.S. generics market
March 6, 2009
FDA says Ranbaxy faked drug data
February 26, 2009
Gilead prowls India for partners, growth
February 13, 2009
China, not M&A, is AZ's promised land
February 6, 2009
FDA regs might hurt Indian pharma companies
December 24, 2008
AstraZeneca outsources IT to India's Infosys
December 15, 2008
India may lose outsourcing deals after Mumbai attacks
December 1, 2008
Pharma bets its chips in developing countries
November 17, 2008
Is the FDA persecuting India's generics makers?
November 17, 2008
Merck's India sub aims for big growth
November 6, 2008
Glaxo regroups sales reps by specialty
November 6, 2008

Paid Research Reports

More Research Reports >>